SLAS Discovery

Papers
(The median citation count of SLAS Discovery is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening73
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models64
In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors46
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei42
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay40
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature37
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery35
Ex vivo discovery of synergistic drug combinations for hematologic malignancies33
A Quantitative Bioassay to Determine the Inhibitory Potency of NGF–TrkA Antagonists29
Bioassay protocol metadata annotation: Proposed standards adoption28
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies27
Protocol for 3D screening of lung cancer spheroids using natural products26
Outline and background for the EU-OS solubility prediction challenge26
An efficient and scalable data analysis solution for automated electrophysiology platforms25
Emerging drug discovery ecosystems25
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-1924
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling24
Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease23
Automation of Organoid Cultures: Current Protocols and Applications22
The Impact of Assay Design on Medicinal Chemistry: Case Studies20
Drug repurposing screen for the rare disease ataxia-telangiectasia20
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin19
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells19
Functional and Pharmacological Comparison of Human and Mouse Na+/Taurocholate Cotransporting Polypeptide (NTCP)19
Role Of Vaccines Against COVID-19 Pandemic19
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer18
Screening for molecular glues – Challenges and opportunities17
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening17
A Perspective on Synthetic Biology in Drug Discovery and Development—Current Impact and Future Opportunities17
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines16
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis16
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice15
In Memoriam14
Development of a live cell assay for the zinc transporter ZnT813
A perspective on the discovery of enzyme activators13
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors13
Protocol to develop A 3D tumor model for drug testing applications13
Screening for modulators of autism spectrum disorder using induced human neurons12
High-Throughput cell-based immunofluorescence assays against influenza12
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons11
Flexible Fitting of PROTAC Concentration–Response Curves with Changepoint Gaussian Processes11
High-throughput screening for identifying acetylcholinesterase inhibitors: Insights on novel inhibitors and the use of liver microsomes11
Development and Validation of High-Content Analysis for Screening HDAC6-Selective Inhibitors11
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells11
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library11
Automated high-throughput, high-content 3D imaging of intact pancreatic islets11
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.10
Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine9
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]9
Deep Learning Image Analysis of High-Throughput Toxicology Assay Images9
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies9
Biochemical and Cellular Profile of NIK Inhibitors with Long Residence Times9
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch9
Phenotypic Screening Following Transcriptomic Deconvolution to Identify Transcription Factors Mediating Axon Growth Induced by a Kinase Inhibitor8
A robust CETSA data analysis automation workflow for routine screening8
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc8
Publisher's Note8
A High-Content Screening Assay for Small Molecules That Stabilize Mutant Triose Phosphate Isomerase (TPI) as Treatments for TPI Deficiency7
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant7
SLAS Discovery – The Next Generation of Research7
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance7
Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health Assay Guidance Man7
Creating a more strategic small molecule biophysical hit characterization workflow7
Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines7
Using chemical and biological data to predict drug toxicity7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols7
High-Throughput Phenotypic Assay for Compounds That Influence Mitochondrial Health Using iPSC-Derived Human Neurons7
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models7
Identification of potent small molecule inhibitors of SARS-CoV-2 entry7
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes7
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase7
Development of a continuous assay for high throughput screening to identify inhibitors of the purine salvage pathway in Plasmodium falciparum6
Development of a High-Throughput, Compound-Multiplexed Fluorescence Polarization Assay to Identify ATG5–ATG16L1 Protein–Protein Interaction Inhibitors6
Characterisation of high throughput screening outputs for small molecule degrader discovery6
WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin6
Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR6
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma6
A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex6
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay6
Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology6
Discovery of Novel HCN4 Blockers with Unique Blocking Kinetics and Binding Properties6
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens6
Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay6
Epithelial Barrier Integrity Profiling: Combined Approach Using Cellular Junctional Complex Imaging and Transepithelial Electrical Resistance5
Thank You to Our 2021 Reviewers5
DeepTI: A deep learning-based framework decoding tumor-immune interactions for precision immunotherapy in oncology5
Protocols in drug discovery5
Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells5
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry5
NMR Reporter Assays for the Quantification of Weak-Affinity Receptor–Ligand Interactions5
Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines5
MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling5
A Biochemical Screening Platform to Target Chromatin States Using Condensates as a Tool5
Identification of Potential Modulators of the RGS7/Gβ5/R7BP Complex5
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening5
Robustness of NanoBiT luciferase complementation technology in the presence of widely used kinase inhibitors5
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors4
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-24
A phenotypic screen for compounds that reverse cAMP-mediated suppression of T cell functions4
Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods4
High-throughput approaches to uncover synergistic drug combinations in leukemia4
Corelet™ platform: Precision high throughput screening for targeted drug discovery of biomolecular condensates4
Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives4
A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications4
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors4
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS4
Development of a live cell assay for real-time monitoring the interactions between the Hippo pathway components 14-3-3 and TAZ4
Addressing Unusual Assay Variability with Robust Statistics4
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction4
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling4
Mathematical relationships between control group variability and assay quality metrics3
Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay3
Fragment-based screening: A new paradigm for ligand and target discovery3
Point-of-use, automated fabrication of a 3D human liver model supplemented with human adipose microvessels3
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors3
A high throughput assay for phosphoribosylformylglycinamidine synthase3
Optimising cell-based bioassays via integrated design of experiments (ixDoE) - A practical guide3
The SLAS Discovery Editor's Top 10 for 20213
Automated quality control tool for high-content imaging data by building 2D prediction intervals on reference biosignatures3
High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy3
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors3
Treating Cells as Reagents to Design Reproducible Assays3
Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment3
Epithelial 3D-spheroids as a tool to study air pollutant-induced lung pathology3
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library3
Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction3
Grouping concentration response curves by features of their shape to aid rapid and consistent analysis of large data sets in high throughput screens3
Drug discovery efforts at George Mason University3
Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase3
Graph neural networks for the identification of novel inhibitors of a small RNA3
Deep phenotyping of surface stimulatory and inhibitory co-receptors on cancer-resident T and NK cells reveals cell subsets within the tumor-reactive CTL population that are uniquely defined by NKG2A e3
Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection3
A “Failed” Assay Development for the Discovery of Rescuing Small Molecules from the Radiation Damage3
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors3
A multi-parametric high throughput assay for detecting beta-cell proliferation in dispersed primary islets3
Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay3
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library3
Compound management in a virtual research organization: The cornerstone of a reliable MMV discovery engine3
Lead identification using 3D models of pancreatic cancer3
Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development3
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA13
Corrigendum to “Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology” [SLAS Discovery, Volume 27 (2022) P140-147/2472-5552]2
Magnetic three-dimensional bioprinting protocol for salivary gland mucoepidermoid carcinoma tumoroid culture2
Identification of chemicals breaking the USP8 interaction with its endocytic substrate CHMP1B2
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids2
The Problems of Applying Classical Pharmacology Analysis to Modern In Vitro Drug Discovery Assays: Slow Binding Kinetics and High Target Concentration2
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins2
Micro/nano topological modification of TiO2 nanotubes activates Thy-1 signaling to control osteogenic differentiation of stem cells2
Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns2
BRET measurement on CCD camera-based microtiter plate readers2
Development of a biotin–streptavidin-enhanced enzyme-linked immunosorbent assay (BA-ELISA) for high-throughput screening of KRASG12C inhibitors2
ATPase activity profiling of three human DExD/H-box RNA helicases2
A mechanism of action-reflective, dual cell-based bioassay for determining the bioactivity of sclerostin-neutralizing antibodies2
HTS discovery of PARP1-HPF1 complex inhibitors in cancer2
WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines2
High throughput screening for compounds to the orphan nuclear receptor NR2F62
Structure-activity relationships of thiadiazole agonists of the human secretin receptor2
Assay Guidance Manual for Drug Discovery: Robust or Go Bust2
High-throughput detection of metal contamination in HTS outputs2
Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer2
High-throughput method to analyze the cytotoxicity of CAR-T Cells in a 3D tumor spheroid model using image cytometry2
The openOCHEM consensus model is the best-performing open-source predictive model in the First EUOS/SLAS joint compound solubility challenge2
0.080246925354004